Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors

The second largest US blood center began testing for antibodies to SARS-CoV-2, the etiologic agent of Coronavirus Disease-2019 (COVID-19) to identify potential COVID-19 Convalescent Plasma (CCP) donors and encourage blood donation. We report the non-vaccine seroprevalence of total immunoglobulin dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassallo, Ralph R., Dumont, Larry J., Bravo, Marjorie D., Hazegh, Kelsey, Kamel, Hany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321959/
https://www.ncbi.nlm.nih.gov/pubmed/34376289
http://dx.doi.org/10.1016/j.tmrv.2021.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321959/
https://www.ncbi.nlm.nih.gov/pubmed/34376289
http://dx.doi.org/10.1016/j.tmrv.2021.07.003

Ejemplares similares